Priligy 60 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

priligy 60 mg filmom obložene tablete

berlin-chemie ag, glienicker weg 125, berlin, njemačka - dapoksetinklorid - filmom obložena tableta - 60 mg - urbroj: jedna filmom obložena tableta sadrži dapoksetinklorida u količini koja odgovara 60 mg dapoksetina

Nubeqa Europska Unija - hrvatski - EMA (European Medicines Agency)

nubeqa

bayer ag - darolutamide - tumori prostate, Кастраци-uporan - endokrinska terapija - nubeqa is indicated for the treatment of adult men with- non metastatic castration resistant prostate cancer (nmcrpc) who are at high risk of developing metastatic disease (see section 5. - metastatic hormone sensitive prostate cancer (mhspc) in combination with docetaxel and androgen deprivation therapy (see section 5.

Clopidogrel Acino Europska Unija - hrvatski - EMA (European Medicines Agency)

clopidogrel acino

acino ag - klopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitrombotska sredstva - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.

Revestive Europska Unija - hrvatski - EMA (European Medicines Agency)

revestive

takeda pharmaceuticals international ag ireland branch - teduglutide - sindromi malapsorpcije - drugi gastrointestinalni trakt i metabolizam, lijekovi, - revestive je indiciran za liječenje bolesnika starijih od jedne godine i više s sindromom kratkog crijeva (sbs). pacijenti bi trebali biti stabilni nakon perioda crijevne adaptacije nakon operacije. revestive indiciran za liječenje bolesnika u dobi od 1 godine i više sa sindromom kratkog crijeva . pacijenti bi trebali biti stabilni nakon perioda crijevne adaptacije nakon operacije.

Xarelto Europska Unija - hrvatski - EMA (European Medicines Agency)

xarelto

bayer ag - rivaroksaban - arthroplasty, replacement; venous thromboembolism - antitrombotska sredstva - xarelto, uvedene zajedno sa ацетилсалициловой kiselinom (ask) sami ili sa asc plus клопидогрел ili Тиклопидин, prikazana za prevenciju атеротромботических događaja kod odraslih pacijenata nakon akutnog koronarni sindrom (acs) s povišenom razinom кардиальных biomarkera. xarelto, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. prevencija venske tromboembolije (vte) u odraslih bolesnika koji se podvrgavaju izborni operacije zamjena kuka ili koljena. liječenje tromboze dubokih vena (dvt) i plućne embolije (ТЭЛА) i prevenciju recidiva dvt i ТЭЛА kod odraslih. adultsprevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Takhzyro Europska Unija - hrvatski - EMA (European Medicines Agency)

takhzyro

takeda pharmaceuticals international ag ireland branch - lanadelumab - angioedemas, nasljedni - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.

Rokuronijev bromid B. Braun 10 mg/ml otopina za injekciju/infuziju Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

rokuronijev bromid b. braun 10 mg/ml otopina za injekciju/infuziju

b. braun melsungen ag, carl-braun-str. 1, melsungen, njemačka - rokuronijev bromid - otopina za injekciju / infuziju - 10 mg/ml - urbroj: svaki ml otopine za injekciju/infuziju sadrži 10 mg rokuronijevog bromida

Defevix 266 mikrograma meke kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

defevix 266 mikrograma meke kapsule

berlin-chemie ag, glienicker weg 125, berlin, njemačka - kalcifediol hidrat - kapsula, meka - urbroj: jedna meka kapsula sadrži 266 mikrograma kalcifediol hidrata

SANDIMMUN NEORAL 100 mg/1 kapsula kapsula, meka Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

sandimmun neoral 100 mg/1 kapsula kapsula, meka

novartis ba d.o.o. - ciklosporin - kapsula, meka - 100 mg/1 kapsula - 1 kapsula, meka sadrži: 100 mg ciklosporina

SANDIMMUN NEORAL 50 mg/1 kapsula kapsula, meka Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

sandimmun neoral 50 mg/1 kapsula kapsula, meka

novartis ba d.o.o. - ciklosporin - kapsula, meka - 50 mg/1 kapsula - 1 kapsula, meka sadrži: 50 mg ciklosporina